| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0004 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0004 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0005 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.21 | 0.0005 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.27 | 0.0005 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0006 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0006 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.19 | 0.0006 |